USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Momentis Surgical Ltd

USPTO PatentsView assignee record - 18 granted patents across 7 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

The verdict

According to USPTO PatentsView, Momentis ranks #16,206 of 50,000 tracked US assignees by granted-patent volume, with 18 patents across 7 technology areas.

#16,206
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.5/100)
19.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R16206 · Foreign Corporation #16,206 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 18 grants
  • MID-PACK #16,206/50,000
  • PHOTO-FINISH Minimax Viking Paten…
  • CPC-NARROW A61B · 7 areas
  • INNOV-PAR 51.5/100
  • CLAIMS-RICH 19.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Minimax Viking Patent Management Gmbh (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Momentis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Momentis Surgical Ltd stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #16,206 of 50,000; Innovation Score 51.5/100 sits in the top 11% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Minimax Viking Patent Management Gmbh (±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Momentis Surgical Ltd has been granted 18 US utility patents between 2022 and 2025, placing Momentis Surgical Ltd at #16,206 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Momentis Surgical Ltd is one of the more focused assignees in the PatentsView dataset. By volume, Momentis sits between Minimax Viking Patent Management Gmbh (18 patents, rank #16,203) and Myant Inc. (18 patents, rank #16,211) - the closest US assignees by grant volume. The composite Innovation Score of 51.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2022 through 2025, with 18 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Momentis Surgical Ltd's 19.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 7 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Momentis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Momentis holds 18 patents at rank #16,207, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Momentis

By rank, the assignees closest to #16,207 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Momentis's primary technology class.

Momentis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2022202320242025 6
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Momentis Surgical Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 2 11.1%
2023 3 16.7%
2024 7 38.9%
2025partial year 6 33.3%

Where it ranks

Overall rank by patents

#16,206

of 50,000 tracked assignees

Innovation Score

51.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.